By one measure the bull market is 16 years old. Here's why investors face a 'challenging decade' ahead.
By Jamie Chisholm
Some of the long-term supportive tailwinds are shifting, according to MRB
The secular bull run is only sixteen, but is already long in the tooth, says one strategist.
Many investors once again buying the dip in equities on Monday will be thinking of the cyclical factors driving stocks: reasonable economic growth and falling interest rates, for example. Again, these are overcoming concerns about pockets of rich valuations.
But underlying such moves are also secular trends that can span several economic cycles, says Phillip Colmar, global strategist at Macro Research Board, the London-based multi-asset research company . On that basis, U.S. equities are in a 16-year secular bull market that began in 2009.
In a note published at the end of last week, Colmar listed the current secular tailwinds. A particularly important trend is what he calls "policy distortions" in recent decades, such as ultralow interest rates and fiscal boosts, that "have cut short recessions and extended expansion phases, by fueling leverage and bringing forward growth from future generations."
In addition, reductions in labor unionization, increased globalization, deregulation, lower corporate taxation and technological advances, have all helped the corporate sector to capture an ever-greater share of economic growth.
The problem, says Colmar, is that some of these trends are "now extended and/or cresting/reversing." Globalization is being challenged by the Trump trade agenda, for example, while a four-decade period of steadily falling inflation and bond yields is over. The latter "poses a material threat to those parts of the equity market with rich valuations," he says.
The important question for investors, therefore, is to what extent this secular bull market may be overextended, just as some of its supports fade. Historical context suggests traders need to be wary.
Colmar says the S&P 500 SPX, or equivalent, has since 1871 completed four secular bull markets and four such bear markets, with their magnitude and duration varying significantly.
But, as the following chart shows, the current bull run has left stocks very elevated relative to their historical trend line. This "provides a potential ominous warning about the road ahead," says Colmar. "Historically, after reaching such an extreme, returns in the subsequent decade have tended to be low."
Source: Macro Research
Even accounting for a step-change in inflation-adjusted stock market trends following the Great Depression in the 1930s, real U.S. equity prices are still elevated and more than 1 standard deviation above trend, Colmar notes. A standard deviation is a statistical measure of how spread out a data set is from its mean.
All together, this means "nosebleed valuations are also becoming an increasing challenge for U.S. equities," says Colmar, with "measures of long-term valuation, such as the Shiller P/E ratio, show[ing] the U.S. equity market is now at historically frothy levels, which limits the scope for further upside."
Source: Macro Research Bond
So, what should investors do? The important thing to note, says Colmar, is that there is significant bifurcation in the market, with "substantially overpriced growth stocks (particularly megacaps) and still relatively attractive value stocks." He calculates that the inflation-adjusted growth stock index is now more than two standard deviations above the long-term trend for the aggregate U.S. market. In contrast, the U.S. value stock index is well below this trend line.
"Although relative earnings trends partially explain the divergence in price performance, relative P/E and price/book valuations highlight that U.S. growth stocks have fully discounted this advantage and are now extremely expensive versus their value counterparts," Colmar says. P/E refers to share price relative to earnings.
It is also the case that U.S. stocks overall are expensive on a 12-month forward P/E ratio of 23 times, versus a historical average of 17 times, whereas an index of global equities minus the U.S. trades at a forward P/E in line with its historical average of 15. In addition, MRB thinks the currently expensive U.S. dollar will weaken, making U.S. stocks less attractive to foreign investors.
"The secular bull run in U.S. equities that began in 2009 is extended, with many of the powerful tailwinds now fully discounted and in some cases cresting/reversing. While a bear market catalyst is still absent, current pricing implies a material deterioration in the risk/reward profile and a challenging decade ahead for equity returns," Colmar concludes.
He suggests global equity investors should diversify away from frothy areas of the U.S. market, though his preference within the U.S. is for financials, industrials, and healthcare. Globally, he suggests equities in the euro area, Japan, and emerging markets.
The markets
U.S. stock-indices SPX DJIA COMP are higher at the opening bell as benchmark Treasury yields BX:TMUBMUSD10Y rise. The dollar index DXY is little changed, while oil prices (CL.1) gain ground and gold futures (GC00) are trading around $4,090 an ounce.
Key asset performance Last 5d 1m YTD 1y S&P 500 6728.8 -1.80% 1.11% 14.40% 12.12% Nasdaq Composite 23,004.54 -3.04% 3.60% 19.13% 19.28% 10-year Treasury 4.133 2.00 9.70 -44.30 -17.70 Gold 4087.3 1.83% -1.03% 54.86% 55.64% Oil 60.03 -1.62% 0.79% -16.47% -11.91% Data: MarketWatch. Treasury yields change expressed in basis points
Need to Know starts early and is updated until the opening bell, but sign up here to get it delivered once to your email box. The emailed version will be sent out at about 7:30 a.m. Eastern.
Take control of your news. Make MarketWatch your preferred source on Google.
The buzz
The end of the longest U.S. government shutdown is more likely after some Democrats supported a deal.
U.S. President Donald Trump on Sunday floated the idea of payments of at least $2,000 to most Americans to show the benefits of his tariff policy.
Pfizer (PFE) beat Novo Nordisk (NVO) in the battle to buy Metsera (MTSR) in a deal that values the biotechnology company at up to $9.1 billion.
Taiwan Semiconductor Manufacturing (TSM) reported slower revenue growth for October, as AI demand eases.
Companies reporting earnings after the closing bell include Occidental Petroleum (OXY), CoreWeave (CRWV) and Rigetti Computing (RGTI).
The Treasury will announce the result of a $58 billion 3-year note auction at 1 p.m. Eastern. Bond markets will be closed on Tuesday for Veterans Day.
Best of the web
How this 31-year-old made $250 million in 30 months.
Genetically engineered babies are banned. Tech titans are trying to make one anyway.
Big Tech needs a staggering $1.5 trillion to fund the AI boom. This is the complex playbook it's using to get it.
The chart
Source: Turning Point Market Research
The S&P 500 has registered 36 record highs this year. "Even more notable is that 31 of those record highs occurred within a rolling four-month window -a feat that has happened only eight other times since 1928," says Turning Point Market Research. Unfortunately, compared with other previous occasions, market breadth is notably much poorer, TPMR notes. "In case you were wondering, the 31st record high in 1929 occurred one day before the peak," they add.
Top tickers
Here were the most active stock-market tickers on MarketWatch as of 6 a.m. Eastern.
Ticker Security name NVDA Nvidia TSLA Tesla BYND Beyond Meat TSM Taiwan Semiconductor Manufacturing PLTR Palantir Technologies GME GameStop AMD Advanced Micro Devices META Meta Platforms WKHS Workhorse AAPL Apple
Random reads
50 km pram-pushing world record.
Sucker fish whale-surfing.
Tutor sought for near-$240k job to teach baby to become a 'gentleman'.
For more market updates plus actionable trade ideas for stocks, options and crypto, subscribe to MarketDiem by Investor's Business Daily.
-Jamie Chisholm
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-10-25 0930ET
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
5 Stocks to Buy Trading at Big Discounts
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
